4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000035
CEO bought 490,500 shares at an average $0.01 ($5,180)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
25 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-28 | Purchase : show line 1 in the form | +30,000 | $0.01 | $300 | 23,505,597 | D |
| 2019-05-28 | Purchase : show line 2 in the form | +20,000 | $0.01 | $200 | 23,525,597 | D |
| 2019-05-28 | Purchase : show line 3 in the form | +50,000 | $0.01 | $500 | 23,575,597 | D |
| 2019-05-28 | Purchase : show line 4 in the form | +50,000 | $0.01 | $525 | 23,625,597 | D |
| 2019-05-28 | Purchase : show line 5 in the form | +25,500 | $0.01 | $268 | 23,651,097 | D |
| 2019-05-28 | Purchase : show line 6 in the form | +10,000 | $0.01 | $104 | 23,661,097 | D |
| 2019-05-28 | Purchase : show line 7 in the form | +20,000 | $0.01 | $210 | 23,681,097 | D |
| 2019-05-28 | Purchase : show line 8 in the form | +50,000 | $0.01 | $575 | 23,731,097 | D |
| Open-market purchases · 490,500 sh · avg $0.01 · $5,180 | ||||||
Loading xslF345X03/primary_doc.xml…